PF4 and autoimmune thrombocytopenic purpura: Such findings not only led the authors to confirm a causal link between vaccination with ChAdOx1 nCov-19 and the development of immune thrombocytopenia mediated by platelet-activating antibodies against Platelet Factor 4 (PF4), but also allowed the production of a few hypotheses on its pathogenicity.